A, P., & A, Z. (2020). ASO Author Reflections: Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma-Predictors of Disease Progression and Performance Status Decline. Annals of surgical oncology, 27(8), 2972. https://doi.org/10.1245/s10434-020-08299-8
Chicago Style (17th ed.) CitationA, Paniccia, and Zureikat A. "ASO Author Reflections: Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma-Predictors of Disease Progression and Performance Status Decline." Annals of Surgical Oncology 27, no. 8 (2020): 2972. https://doi.org/10.1245/s10434-020-08299-8.
MLA (9th ed.) CitationA, Paniccia, and Zureikat A. "ASO Author Reflections: Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma-Predictors of Disease Progression and Performance Status Decline." Annals of Surgical Oncology, vol. 27, no. 8, 2020, p. 2972, https://doi.org/10.1245/s10434-020-08299-8.